Panacea Biotech has signed two agreements with Serum Institute of India (SII) and Bilthovan Biologicals (BBIO). Under this collaboration, SII is entitled to manufacture and sell fully liquid whole cell Pertussis (wP) and salk-based injectable polio vaccine (IPV), developed by Panacea Biotech.